Marker Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Marker Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Marker Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Marker Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $54k | 19k | 2.82 |
2024-03-31 | $1.8k | 427 | 4.30 |
2023-09-30 | $421 | 93 | 4.54 |
2023-06-30 | $4.7k | 1.5k | 3.10 |
2023-03-31 | $4.0k | 5.6k | 0.71 |